CIPLA
Back to All Ratios
|
CIPLA Last 5 Year Total Debt/Mcap History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Debt/Mcap(x) | - | - | 0.01 | 0.01 | 0.03 |
What is the latest Total Debt/Mcap ratio of CIPLA ?
Year | Total Debt/Mcap |
---|---|
Mar2025 | - |
Mar2024 | - |
Mar2023 | 0.01 |
Mar2022 | 0.01 |
Mar2021 | 0.03 |
How is Total Debt/Mcap of CIPLA Trending?
Years | Total Debt/Mcap | % Change | |
---|---|---|---|
Mar2025 | 0 | 0 | |
Mar2024 | 0 | -100.00 | |
Mar2023 | 0.01 | 0.00 | |
Mar2022 | 0.01 | -66.67 | |
Mar2021 | 0.03 | - |
Other Financial Ratios of CIPLA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover |
Compare Total Debt/Mcap ratio of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹122,434.2 Cr | 0.3% | -3.5% | -10.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,063.0 Cr | 0.5% | 4.6% | -18.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,749.0 Cr | -3.2% | -6.7% | 4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,928.0 Cr | 0.9% | -0.6% | 3.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,168.0 Cr | -2.2% | -0.9% | -9.4% | Stock Analytics | |
MANKIND PHARMA | ₹101,089.0 Cr | -3.2% | -4.1% | -6% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 0.3% |
-3.5% |
-10.2% |
SENSEX | 0.1% |
1.3% |
-5.1% |
You may also like the below Video Courses